Lapinig, Benita D.
HRN: 00-55-95 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2022
CEFTRIAXONE 1G (VIAL)
08/03/2022
08/09/2022
IV
2g
Q24
CAP MR
Waiting Final Action
08/03/2022
REMDESIVIR 100MG (VIAL)
08/03/2022
08/08/2022
IV
100mg
Q24
Covid Severe
Waiting Final Action